CAS RN: 168626-94-6
Conivaptan hydrochloride
Product Availability
Choose a grade to view its available package options.
1 package records 1 with current stock 1 grade group
Grade
10 mM in DMSO (1)
In stock only
Batch No. Package Availability Inquiry
Batchno.20250215
1ml
In stock
Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 0.1g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 168626-94-6
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
0.1g
≥95%
0
Out of Stock
Shenzhen
Inquiry
168626-94-6 / N-[4-(2-methyl-4,5-dihydro-3H-imidazo[4,5-d][1]benzazepine-6-carbonyl)phenyl]-2-phenylbenzamide;hydrochloride
Standard CAS: 168626-94-6
Multi CAS: No
Basic Information
copy
CAS
168626-94-6 copy
Multi CAS
No copy
Molecular Formula
C32H27ClN4O2 copy
Molecular Weight
535.000000 copy
Exact Mass
534.182254 copy
SMILES
CC1=NC2=C(N1)CCN(C3=CC=CC=C32)C(=O)C4=CC=C(C=C4)NC(=O)C5=CC=CC=C5C6=CC=CC=C6.Cl copy
InChI
InChI=1S/C32H26N4O2.ClH/c1-21-33-28-19-20-36(29-14-8-7-13-27(29)30(28)34-21)32(38)23-15-17-24(18-16-23)35-31(37)26-12-6-5-11-25(26)22-9-3-2-4-10-22;/h2-18H,19-20H2,1H3,(H,33,34)(H,35,37);1H copy
InChIKey
BTYHAFSDANBVMJ-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
39 copy
Aromatic heavy atom count
29 copy
Fraction Csp3
0.09 copy
Rotatable bonds
4 copy
H-bond acceptors
3 copy
H-bond donors
2 copy
Molar refractivity
157.66 copy
TPSA
78.09 copy
LogP / Solubility
WLOGP
6.93 copy
MLOGP
6.14 copy
XLogP3
6.93 copy
Consensus LogP
6.67 copy
Log S (ESOL)
-7.81 copy
Class (ESOL)
Insoluble copy
Log S (Ali)
-8.95 copy
Class (Ali)
Insoluble copy
Log S (SILICOS-IT)
-9.37 copy
Class (SILICOS-IT)
Insoluble copy
ADME
GI absorption
Low copy
BBB permeant
No copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
Yes copy
CYP2C9 inhibitor
Yes copy
CYP2D6 inhibitor
Yes copy
CYP3A4 inhibitor
Yes copy
Log Kp (skin permeation)
-1.06 copy
Drug-likeness / Medicinal Chemistry
Lipinski
No copy
Ghose
No copy
Veber
Yes copy
Egan
No copy
Muegge
No copy
Bioavailability score
0.17 copy
Leadlikeness
No copy
Synthetic Accessibility
5.5 copy
Safety & Transport
copy
Pictogram(s)
Health Hazard copy
Signal
Warning copy
GHS Hazard Statements
H361fd (100%): Suspected of damaging fertility; Suspected of damaging the unborn child [Warning Reproductive toxicity] copy
Precautionary Statement Codes
P203, P280, P318, P405, and P501 copy